Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
IRMD
REPL
Add up to 3 more stocks
IRMD
IRadimed Corporation
-2.02%
$84.72-1.75Delayed quote: Oct 6, 2026, 3:15 PM EDT
Market Cap
$1.08B
52W Range
$71.34 - $107.90
REPL
Replimune Group, Inc.
-0.12%
$13.13-0.02Delayed quote: Oct 6, 2026, 3:15 PM EDT
Market Cap
$1.10B
52W Range
$1.50 - $16.33
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 47.33 | N/A |
| Forward P/E | 40.09 | N/A |
| PEG Ratio | 0.64 | N/A |
| P/B Ratio | 10.64 | 10.45 |
| P/S Ratio | 12.54 | N/A |
| P/FCF Ratio | 43.44 | N/A |
| EV/EBITDA | 34.81 | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 75.9% | 0.0% |
| Operating Margin | 31.9% | 0.0% |
| Net Margin | 26.7% | 0.0% |
| ROE | 22.7% | -281.1% |
| ROA | 20.1% | -117.7% |
| ROIC | 20.2% | -139.1% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 9.46 | 5.23 |
| Quick Ratio | 8.13 | 5.23 |
| Debt/Equity | 0.00 | 1.06 |
| Interest Coverage | N/A | -36.11 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | 1.5% | N/A |
| Payout Ratio | 71.0% | N/A |
| Yrs of Dividend Growth | 1 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.